Blog

Medimo | Pharmacovigilance

A blackout in Spain, a possibility of delay in the Nordics – Why pharmacovigilance must be prepared

July 1, 2025July 1, 2025

Pharmacovigilance

Medimo’s role as a local pharmacovigilance contact: expert support in ensuring human and veterinary medicine safety

May 26, 2025May 26, 2025

Medimo | Promotional material

Navigating pharmaceutical marketing rules and regulations

April 22, 2025April 22, 2025

Medimo | Pharmacovigilance

Protecting consumers: Why are medicines recalled?

March 19, 2025March 19, 2025

Medimo | Pharmacovigilance

ATMP products: A new era of medical treatments and Medimo’s expertise

March 6, 2025March 11, 2025

Pharmacovigilance

ATMP (Advanced Therapy Medicinal) products and QP role

January 31, 2025March 6, 2025

Regulatory affairs

Current Insights: Experiences from the Marketing Authorization Seminar 2024

October 18, 2024October 18, 2024

Medimo

Medimo Oy wishes you a wonderful and sunny summer!

June 28, 2024June 28, 2024

Auditing | Pharmacovigilance

Inside auditing: Quality assurance of manufacturing and distribution in the pharmaceutical industry

March 7, 2024March 7, 2024

Auditing | Pharmacovigilance

Why should pharmacovigilance be audited? Why is it important?

October 23, 2023October 23, 2023